Oman vs Qatar: Breast cancer death rate in women
Oman
5.56 deaths per 100,000 people
in 2021
Qatar
5.85 deaths per 100,000 people
in 2023
Oman rank
106th
Qatar rank
104th
Breast cancer death rate in women over time
- Oman
- Qatar
How they compare
Qatar currently reports 5.85 deaths per 100,000 people against 5.56 deaths per 100,000 people in Oman, a difference of 0.29 deaths per 100,000 people.
That makes Qatar's figure about 1.1 times Oman's.
Across all 8 years both countries report, Qatar has been ahead every year.
Oman ranks 106th and Qatar ranks 104th of 111 countries.
Qatar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Oman | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.69 deaths per 100,000 people | 16.54 deaths per 100,000 people | 11.85 deaths per 100,000 people | Qatar |
| 2010s | 3.29 deaths per 100,000 people | 15.54 deaths per 100,000 people | 12.25 deaths per 100,000 people | Qatar |
| 2020s | 6.06 deaths per 100,000 people | 13.25 deaths per 100,000 people | 7.19 deaths per 100,000 people | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher breast cancer death rate in women, Oman or Qatar?
- Qatar, at 5.85 deaths per 100,000 people against 5.56 deaths per 100,000 people in Oman as of 2023.
- What is the difference in breast cancer death rate in women between Oman and Qatar?
- 0.29 deaths per 100,000 people, with Qatar ahead.
- How many years of comparable data are there for Oman and Qatar?
- 8 years are reported by both, from 2009 to 2021.
- How do Oman and Qatar rank globally for breast cancer death rate in women?
- Oman ranks 106th and Qatar ranks 104th of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Breast cancer death rate in women. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from breast cancer in females in those aged all ages per 100,000 people.